Remove Insulin Remove Marketing Remove Packaging Remove Pharma Companies
article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. This will also mean the industry needs to think about how HCPs will want to interact with pharma companies. “If

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52
article thumbnail

Which Arthritis Painkiller Works the Fastest?

The Pharma Data

Unfortunately, I learned the hard way that the “Big Pharmacompanies don’t care about their patients. Jonathan was in his late 40s and came into my pharmacy to pick up his insulin for his diabetes, when he told me about his father. It’s all about the bottom line, at any cost. Frequently Asked Questions.